Abbott has secured the US FDA approval for its next generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring.
Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary incontinence (UUI).
Synergy Spine Solutions has received PMA from the FDA for the Synergy Disc, expanding cervical disc replacement options for US patients.